Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual vs Oral Zolmitriptan for Cluster Headache
NCT03377257Phase 4Unknown
- Sponsor
- Xijing Hospital
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of zolmitriptan in Cluster Headache (CH), sponsored by Xijing Hospital. Primary endpoint: Visual Analogue Scale points reduction at 15 months. Status: unknown.
02
Drugs
zolmitriptan
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT03377257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03377257.